CBS News anchor Katie Couric and physicians from The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian will host a seminar on screening for colon cancer at the Center on Thursday, March 26, 2009. The seminar is free and open to the public.

Weill Cornell Science Briefs is an electronic newsletter published by the Office of Public Affairs that focuses on innovative medical research and patient care at Weill Cornell Medical College and NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The newsletter is sent electronically to journalists and available to all on this Web site.

The skull base is not just a simple platform for the brain but an anatomically intricate area with an array of connections necessary to the body's essential functions. Traditionally, a tumor or aneurysm in this area was either inoperable or involved significant risk. Now, new surgical techniques are greatly improving patient outcomes.

Love is in the air, but Valentine's Day shouldn't be the only time to express love for your partner; rather, it should serve as a reminder to devote time and energy to your relationship every day.

On March 25th 2009, Steven J. Corwin, MD, the Executive Vice President and Chief Operating Officer at NewYork-Presbyterian Hospital, appeared on NBC Nightly News With Brian Williams to discuss electronic medical records.

A new book by Dr. Panchali Dhar, an anesthesiologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, called "Before the Scalpel: What Everyone Should Know About Anesthesia" (Tell Me Press) demystifies the process and terms associated with anesthesia and arranges the information in an easy-to-understand, topic-by-topic sourcebook.

Depression in older adults too often goes unrecognized and untreated, resulting in untold misery, worsening of medical illness, and early death. A new study has identified one important remedy: Adding a trained depression care manager to primary care practices can increase the number of patients receiving treatment, lead to a higher remission rate of depression, and reduce suicidal thoughts.

Final results of a pivotal Phase 2 clinical trial of pralatrexate (PDX) for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) were reported by the study's principal investigator, Dr. Owen A. O'Connor of the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center and NewYork-Presbyterian Hospital/Columbia. T-cell lymphoma (PTCL) is a biologically diverse group of blood cancers that account for as many as 15 percent of non-Hodgkin's lymphoma (NHL) cases in the United States.